Quantcast

Latest FDA Stories

2014-08-25 23:10:03

The Manhattan Institute's Project FDA launches series of public discussions on bio-innovation. Boston, MA (PRWEB) August 25, 2014 The Manhattan Institute (MI) and its Project FDA, in partnership with the Tufts Center for the Study of Drug Development, will host the first in a series of public discussions about the reforms necessary to accelerate patient access to life-saving treatments, lower the cost of developing and delivering better treatments, and maintain America’s place as...

2014-08-25 23:03:22

ComplianceOnline, the leading GRC advisory network, and renowned regulatory affairs expert, Karl M. Nobert will conduct a two day seminar on the veterinary drug approval process and FDA regulatory oversight. Chicago, IL (PRWEB) August 25, 2014 ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on The Veterinary Drug Approval Process and FDA Regulatory Oversight. The two day seminar...

2014-08-25 16:27:49

WASHINGTON, Aug. 25, 2014 /PRNewswire-USNewswire/ -- The following is a statement of Susan M. Liss, Executive Director, Campaign for Tobacco-Free Kids: http://photos.prnewswire.com/prnvar/20080918/CFTFKLOGO The number of U.S. youth who used electronic cigarettes, but have never smoked a regular cigarette, has more than tripled in the past three years, from 79,000 in 2011 to over 263,000 in 2013. And these youth are nearly twice as likely to intend to smoke regular cigarettes as...

2014-08-25 08:28:30

Multimedia assets associated with the below announcement are now available. Assets include: b-roll footage, corporate sound bites, product images and additional information. Please click: http://www.multivu.com/players/English/7197331-viiv-healthcare-vhc-triumeq-fda-approval LONDON, Aug. 25, 2014 /PRNewswire/ -- On August 22, ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Triumeq(®) (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the...

2014-08-25 08:27:26

New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug. 25, 2014 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug Administration (FDA) has approved ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain. This marks the second indication...

2014-08-22 23:08:21

For generic drugmakers, Oct. 1 is crunch time and is the date after which all ANDA amendment and prior-approval supplement applications must meet new performance goals under the Generic Drug User Fee Amendments (GDUFA) of 2012. Joan Janulis, a Hatch-Waxman pro and all-around expert on FDA regulation in the generic drug industry, will help attendees read between the lines of the GDUFA performance metrics, associated guidance documents and MAPPs, and provide a roadmap to the post-GDUFA...

2014-08-22 23:07:45

On August 19, the FDA announced that certain lots of the Diamondback 360 Peripheral Orbital Atherectomy Systems, by Cardiovascular Systems, are recalled because they may contain sheath that can fracture during use. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-08-22 23:05:03

Cryo-Cell International, Inc., the world’s first cord blood bank, announced today that it has provided funding to complete an Investigational New Drug Application (IND) for a FDA approved Phase I clinical trial for patients that have amyotrophic lateral sclerosis (ALS or Lou Gehrig's) disease using umbilical cord blood cells. Oldsmar, FL (PRWEB) August 22, 2014 This funding was made through an additional investment in Cryo-Cell’s cell therapy research affiliate, Saneron CCEL...

2014-08-22 23:01:35

The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly suffered the spread of uterine cancers due to the use of the devices in laparoscopic hysterectomies and fibroid removal surgeries. New York, New York (PRWEB) August 22, 2014 As the controversy surrounding the use of power morcellators (http://www.injurybeacon.com/power-morcellator/) in uterine surgeries continues to grow, Bernstein Liebhard LLP notes that several Massachusetts insurance companies have...

Antibacterial Soap Triclosan
2014-08-22 03:00:42

Steve Tokar, UC San Francisco UCSF-Led Study Finds Exposure to Hormone Disruptor from Soap Exceeds that from Toothpaste Handwashing with antibacterial soap exposes hospital workers to significant and potentially unsafe levels of triclosan, a widely-used chemical currently under review by the U.S. Food and Drug Administration, according to a study led by researchers from UC San Francisco. Triclosan, a synthetic antibacterial agent, is found in thousands of consumer products, including...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related